Near future
No Result
View All Result
June 2 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

The celiac disease vaccine enters phase 3

October 24, 2019
Gianluca RiccioGianluca Riccio
⚪ 2 minutes
Share145Pin28Tweet77SendShare21ShareShare15

READ THIS IN:

Celiac disease is an inherited autoimmune disease that causes damage to intestinal microvilli when gluten is consumed.

There is no real cure for celiac disease, a celiac pill that works magic. However, Northwestern University researchers plan to change that with a celiac vaccine that "immunizes" the patient.

We are very close

After the second phase of the tests started in August, the results continue to be among the best.

How the vaccine for celiac disease works

The new approach is based on a simple idea: to make the immune system tolerant to gluten. To do this, the gliadin glycoprotein, which is part of gluten, is loaded into tiny nanocapsules. The nanodoses released into the body stimulate the development of an autoimmune reaction.  

The tests

During the test, the participants received two injections of nanoparticles. Seven days after receiving the second treatment celiac vaccine, the researchers tested their response to gluten. During the first three days, participants received 12 g of gluten per day and for the next 11 days an additional 6 grams.

The article continues after the related links

Moderna: "Cancer and heart disease vaccines ready by 2030"

Approved the first vaccine against plague of bees

According to the scientists, the patients in the treated group tolerated gluten intake much better. The concentration of inflammation markers in them was 90% lower than in the control group. Although only 34 people took part in the studies, the result of the tests they underwent was the first evidence of the effectiveness of the treatment in humans.

The authors note that the nanocapsules can also be used to treat other autoimmune diseases, including allergies, type 1 diabetes and multiple sclerosis.

After the third phase of clinical trials, the FDA can accelerate the approval of this nanoparticle treatment that can "cure" 90% of people with celiac disease. 

The pharmaceutical company Takeda has already received a license for advanced therapy.

Tags: celiac diseasegluten-freeglutenvaccines


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Most read of the week

  • Oculus gives VR visit to the Anne Frank house

    268 Shares
    Share 107 Tweet 67
  • Here comes a new magnetic field reversal. We are ready?

    4 Shares
    Share 1 Tweet 1
  • Sucralose, the bitter truth: the sweetener damages DNA

    3 Shares
    Share 1 Tweet 1
  • Look what's on my mind: an AI that transforms thoughts into HQ Videos

    4 Shares
    Share 1 Tweet 1
  • Goodbye camera: here is the electronic eye that "sees" like us

    9 Shares
    Share 1 Tweet 1

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok
  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Inland solutions
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Русское издание
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2022 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+